WO2001075044A3 - Nouveau polypeptide, proteine ribosomale humaine s18-18, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, proteine ribosomale humaine s18-18, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001075044A3 WO2001075044A3 PCT/CN2001/000444 CN0100444W WO0175044A3 WO 2001075044 A3 WO2001075044 A3 WO 2001075044A3 CN 0100444 W CN0100444 W CN 0100444W WO 0175044 A3 WO0175044 A3 WO 0175044A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- human ribosomal
- ribosomal protein
- discloses
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 102000002278 Ribosomal Proteins Human genes 0.000 title abstract 2
- 108010000605 Ribosomal Proteins Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 210000003705 ribosome Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L"invention concerne un nouveau polypeptide, une protéine ribosomale humaine S18-18, et un polynucléotide codant pour ce polypeptide ainsi qu"un procédé d"obtention de ce polypeptide par des techniques recombinantes d"ADN. L"invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l"hémopathie, de l"infection par VIH, de maladies immunitaires et de diverses inflammations. L"invention concerne aussi l"antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine ribosomale humaine S18-18.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU60024/01A AU6002401A (en) | 2000-03-28 | 2001-03-26 | A novel polypeptide, human ribosomal protein s18-18 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00115206.8 | 2000-03-28 | ||
| CN 00115206 CN1315404A (zh) | 2000-03-28 | 2000-03-28 | 一种新的多肽——人核糖体蛋白s18－18和编码这种多肽的多核苷酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075044A2 WO2001075044A2 (fr) | 2001-10-11 |
| WO2001075044A3 true WO2001075044A3 (fr) | 2002-08-08 |
Family
ID=4584674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000444 WO2001075044A2 (fr) | 2000-03-28 | 2001-03-26 | Nouveau polypeptide, proteine ribosomale humaine s18-18, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1315404A (fr) |
| AU (1) | AU6002401A (fr) |
| WO (1) | WO2001075044A2 (fr) |
-
2000
- 2000-03-28 CN CN 00115206 patent/CN1315404A/zh active Pending
-
2001
- 2001-03-26 WO PCT/CN2001/000444 patent/WO2001075044A2/fr active Application Filing
- 2001-03-26 AU AU60024/01A patent/AU6002401A/en not_active Abandoned
Non-Patent Citations (2)
| Title |
|---|
| DATABASE PROTEIN [online] 22 October 1998 (1998-10-22), WALTER L., retrieved from GI:2879884 accession no. NCBI Database accession no. (CAA11259.1) * |
| DATABASE PROTEIN [online] 30 September 1999 (1999-09-30), CHASSIN D. ET AL., retrieved from GI:6006558 accession no. NCBI Database accession no. (CAB56794.1) * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001075044A2 (fr) | 2001-10-11 |
| AU6002401A (en) | 2001-10-15 |
| CN1315404A (zh) | 2001-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075044A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s18-18, et polynucleotide codant pour ce polypeptide | |
| WO2001075041A3 (fr) | Nouveau polypeptide, proteine humaine associee a l'epilepsie 11, et polynucleotide codant pour ce polypeptide | |
| WO2001083677A3 (fr) | Nouveau polypeptide, proteine humaine fh2-13 de deformation des ailes de coq, et polynucleotide codant pour ce polypeptide | |
| WO2001083758A3 (fr) | Nouveau polypeptide, dihydroorotase humaine 8, et polynucleotide codant pour ce polypeptide | |
| WO2002008427A1 (fr) | Nouveau polypeptide, pompe sodium-potassium humaine 9,57, et polynucleotide codant ce polypeptide | |
| WO2001083680A3 (fr) | Nouveau polypeptide, glycinamide ribonucleotide synthetase humaine 11, et polynucleotide codant pour ce polypeptide | |
| WO2001079424A3 (fr) | Nouveau polypeptide, facteur humaine de couplage d'atpase mitochondriale 6-10, et polynucleotide codant pour ce polypeptide | |
| WO2001079429A3 (fr) | Nouveau polypeptide, facteur humain d'echange guanine nucleotide 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001083676A3 (fr) | Nouveau polypeptide, phosphatase humaine 10 fortement striee, et polynucleotide codant pour ce polypeptide | |
| WO2001079430A3 (fr) | Nouveau polypeptide, serine protease humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001074993A3 (fr) | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide | |
| WO2001045729A8 (fr) | Nouveau polypeptide, phosphoproteine ribosomale humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2001075028A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide | |
| WO2001075030A3 (fr) | Nouveau polypeptide, tyrosinase humaine 11, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001079436A3 (fr) | Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075057A3 (fr) | Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide | |
| WO2001079423A3 (fr) | Nouveau polypeptide, proteine humaine bcr 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075038A3 (fr) | Nouveau polypeptide, serine hydrolase humaine 9 atp-dependante, et polynucleotide codant pour ce polypeptide | |
| WO2001075055A3 (fr) | Nouveau polypeptide, quinine reductase humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075060A3 (fr) | Nouveau polypeptide, cysteine protease humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |